These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 23900887

  • 1. Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.
    Gómez-Bravo MA, Salcedo M, Fondevila C, Suarez F, Castellote J, Rufian S, Pons JA, Alamo JM, Millán O, Brunet M.
    J Clin Pharmacol; 2013 Nov; 53(11):1146-54. PubMed ID: 23900887
    [Abstract] [Full Text] [Related]

  • 2. Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.
    Provenzani A, Notarbartolo M, Labbozzetta M, Poma P, Vizzini G, Salis P, Caccamo C, Bertani T, Palazzo U, Polidori P, Gridelli B, D'Alessandro N.
    Int J Mol Med; 2011 Dec; 28(6):1093-102. PubMed ID: 21922127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
    Staatz CE, Goodman LK, Tett SE.
    Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
    [Abstract] [Full Text] [Related]

  • 5. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
    Cho JH, Yoon YD, Park JY, Song EJ, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.
    Transplant Proc; 2012 Jan; 44(1):109-14. PubMed ID: 22310591
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation.
    Bouamar R, Hesselink DA, van Schaik RH, Weimar W, Macphee IA, de Fijter JW, van Gelder T.
    Ther Drug Monit; 2011 Apr; 33(2):178-84. PubMed ID: 21383650
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
    Jun KR, Lee W, Jang MS, Chun S, Song GW, Park KT, Lee SG, Han DJ, Kang C, Cho DY, Kim JQ, Min WK.
    Transplantation; 2009 Apr 27; 87(8):1225-31. PubMed ID: 19384171
    [Abstract] [Full Text] [Related]

  • 8. CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation.
    Hu R, Barratt DT, Coller JK, Sallustio BC, Somogyi AA.
    Basic Clin Pharmacol Toxicol; 2018 Sep 27; 123(3):320-326. PubMed ID: 29603629
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms.
    Op den Buijsch RA, Christiaans MH, Stolk LM, de Vries JE, Cheung CY, Undre NA, van Hooff JP, van Dieijen-Visser MP, Bekers O.
    Fundam Clin Pharmacol; 2007 Aug 27; 21(4):427-35. PubMed ID: 17635182
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.
    Zhang X, Wang Z, Fan J, Liu G, Peng Z.
    Eur J Clin Pharmacol; 2011 Aug 27; 67(8):803-13. PubMed ID: 21359536
    [Abstract] [Full Text] [Related]

  • 14. CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III).
    Yoon SH, Cho JH, Kwon O, Choi JY, Park SH, Kim YL, Yoon YR, Won DI, Kim CD.
    Transplantation; 2013 Mar 27; 95(6):828-34. PubMed ID: 23364483
    [Abstract] [Full Text] [Related]

  • 15. Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantation.
    Chen YK, Han LZ, Xue F, Shen CH, Lu J, Yang TH, Zhang JJ, Xia Q.
    PLoS One; 2014 Mar 27; 9(10):e109464. PubMed ID: 25310192
    [Abstract] [Full Text] [Related]

  • 16. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.
    Shi Y, Li Y, Tang J, Zhang J, Zou Y, Cai B, Wang L.
    Gene; 2013 Jan 10; 512(2):226-31. PubMed ID: 23107770
    [Abstract] [Full Text] [Related]

  • 17. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients.
    Cusinato DA, Lacchini R, Romao EA, Moysés-Neto M, Coelho EB.
    Br J Clin Pharmacol; 2014 Aug 10; 78(2):364-72. PubMed ID: 24528196
    [Abstract] [Full Text] [Related]

  • 18. Association of CYP3A4-392A/G, CYP3A5-6986A/G, and ABCB1-3435C/T Polymorphisms with Tacrolimus Dose, Serum Concentration, and Biochemical Parameters in Mexican Patients with Kidney Transplant.
    Alatorre-Moreno EV, Saldaña-Cruz AM, Pérez-Guerrero EE, Morán-Moguel MC, Contreras-Haro B, López-de La Mora DA, Dávalos-Rodríguez IP, Marín-Medina A, Rivera-Cameras A, Balderas-Peña LA, Gómez-Ramos JJ, Cortés-Sanabria L, Salazar-Páramo M.
    Genes (Basel); 2024 Apr 16; 15(4):. PubMed ID: 38674430
    [Abstract] [Full Text] [Related]

  • 19. Influence of CYP3A5 genotypes on tacrolimus dose requirement: age and its pharmacological interaction with ABCB1 genetics in the Chinese paediatric liver transplantation.
    Yang TH, Chen YK, Xue F, Han LZ, Shen CH, Zhou T, Luo Y, Zhang JJ, Xia Q.
    Int J Clin Pract Suppl; 2015 May 16; (183):53-62. PubMed ID: 26176181
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms.
    Miyata Y, Akamatsu N, Sugawara Y, Kaneko J, Yamamoto T, Suzuki H, Arita J, Sakamoto Y, Hasegawa K, Tamura S, Kokudo N.
    Ann Transplant; 2016 Aug 09; 21():491-9. PubMed ID: 27503662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.